Diabetic angiopathy: Tracking down the culprits

Journal of Diabetes and its Complications

Volumn 10, Issue 3, 1996, Pages 173-181

  Tooke, John E ^a,d   Shore, Angela C ^a   Cohen, Richard A ^b   Kluft, Cornelis ^c  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b University Hospital   (United States)

^c TNO   (Netherlands)

^d PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; ENDOTHELIUM CELL; HEMOSTASIS; HYPERGLYCEMIA; MICROCIRCULATION; PRIORITY JOURNAL;

EID: 0030152920     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(96)00035-9     Document Type: Article

References (43)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993.
2. Tooke JE: Microvascular function in human diabetes: A physiological perspective. Diabetes 44:721-726, 1995.
3. Jaap AJ, Tooke JE: Pathophsiology of microvascular disease in non-insulin-dependent diabetes. Clin Sci 89:3-12, 1995.
4. Hester RL, Eraslan A, Saito Y: Differences in ENDO contribution to arteriolar diameters at rest and during func-tional dilation in striated muscle. Am J Physiol 265:H148-H151, 1993.
5. Tooke JE: Microcirculation and diabetes. Br Med Bull 45:206-223, 1989.
6. Kastrup J, Norgaard T, Parving H-H, Henriksen O, Lassen NA: Impaired autoregulation of blood flow in subcutaneous tissue of long-term type 1 (insulin-dependent) diabetic patients with microangiopathy: An index of arteriolar dysfunction. Diabetologia 28:711-717, 1985.
7. Parving H-H, Kastrup H, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS: Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 27:547-552, 1984.
8. Parving H-H, Viberti GC, Keen H, Christiansen JS, Lassen NA: Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 32:943-949, 1983.
9. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410-415, 1981.
10. Fujihara CK, Padilha RM, Zatz R: Glomerular abnormalities in long-term experimental diabetes: Role of hemody-namic and nonhemodynamic factors and effects of antihypertensive therapy. Diabetes 41:286-293, 1992.
11. Shore AC, Sandeman DD, Tooke JE: Capillary pressure pulse pressure amplitude and pressure waveform in healthy volunteers. Am J Physiol 268:H147-H154, 1995.
12. Sandeman DD, Shore AC, Tooke JE: Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 327:760-764, 1992.
13. Shore AC, Donohoe M, Jaap AJ, Tooke JE: The effect of increasing doses of an angiotensin converting enzyme inhibitor on capillary pressure levels in patients with insulin-dependent-diabetes mellitus and microalbuminuria [Abstract]. Diabetic Med 10(suppl 1):A18.55, 1993.
14. Jaap AJ, Shore AC, Tooke JE: Capillary filtration coefficient is different in long duration type I diabetic patients with and without microvascular complications [Abstract]. Diabetic Med 11(suppl 1):S13, 1994.
15. Hommel E, Mathiesen ER, Aukland K, Paving H-H: Pathophysiological aspects of edema formation in diabetic nephropathy. Kidney Int 38:1187-1192, 1990.
16. Bent-Hansen L, Feldt-Rasmussen B, Kverneland A, Deckert T: Transcapillary escape rate and relative metabolic clearance of glycated and non-glcated albumin in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:2-4, 1987.
17. Fauchald P, Norseth J, Jervell J: Tanscapillary colloid osmotic gradient, plasma volume and interstitial fluid volume in long-term type I (insulin-dependent) diabetes. Diabetologia 28:269-273, 1985.
18. Shore AC, Jaap AJ, Tooke JE: Capillary pressure in patients with NIDDM. Diabetes 43:1198-1202, 1994.
19. Jaap AJ, Shore AC, Gamble J, Gartside IB, Tooke JE: Capillary filtration coefficient in type II (non-insulin-dependent) diabetes. J Diabet Complications 8:111-116, 1994.
20. Sanderman DD, Pym CA, Green EM, Seamark C, Shore AC, Tooke JE: Microvascular vasodilatation in feet of newly diagnosed non-insulin dependent diabetic patients. BMJ 302:1122-1123, 1991.
21. Cohen RA: Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87:V67-V76, 1993.
22. Ruderman NB, Haudenschild CC: Diabetes as an atherogenic factor. Prog Cardiovasc Dis XXVI:373-412, 1984.
23. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med 328:1676-1685, 1993.
24. Winocour PD: Platelet abnormalities in diabetes mellitus. Diabetes 41:26-31, 1992.
25. Cohen RA: The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 38:105-128, 1995.
26. Cayatte AJ, Palacino JJ, Horten K, Cohen RA: Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 14:753-759, 1994.
27. Cohen RA, Vanhoutte PM: Endothelium-dependent hyperpolarization: Bevond nitric oxide and cyclic GMP. Circulation 92:3337-3349, 1995.
28. Mecham RP, Whitehouse LA, Wrenn DS, Parks WC, Griffen GL, Senior RM, Crouch EC, Stenmark KR, Voelkel NF: Smooth muscle-mdeiated connective tissue remodelling in pulmonary hypertension. Science 237:423-426, 1987.
29. Sarges R, Oates PJ: Aldose reductase inhibitors: Recent developments, In: Progress in Drug Research, Basel, 1993, pp. 99-161.
30. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van Den Eden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications Diabetes 42:801-813, 1993.
31. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991.
32. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988.
33. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 14:978-986, 1993.
34. Hackett D, Davies G, Chierchia S, Maseri A: Intermittent coronary occlusion in acute myocardial infarction: Value of combined thrombolytic and vasodilator therapy. N Engl J Med 317:1055-1059, 1987.
35. Kluft C: Disorders of the haemostatic system and the risk of development of thrombotic and cardiovascular diseases. Am J Obstet Gynecol 163:305-312, 1960.
36. Pedersen OD, Munkvad S, Gram J, Kluft C, Jespersen J: Depression of factor XII-dependent fibrinolytic activity in survivors of acute myocardial infarction at risk of reinfarction. Eur Heart J 14:785-789, 1993.
37. Eriksson E, Kallin B, Van't Hooft FM, Bavenholm P: Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 92:1851-1855, 1995.
38. Juhan-Vague I, Alessi MC, Vague P: Increased plasma plasminogen activator inhibitor 1 levels: A possible link between insulin resistance and atherothrombosis. Diabetologia 34:457-462, 1991.
39. Potter Van Loon BJ, Kluft C, Radder JK, Blankenstein MA, Meinders AE: The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism 42:945-949, 1993.
40. Kluft C: Constitutive synthesis of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1): Conditions and therapeutic targets. Fibrinolysis 8(suppl 2):1-7, 1994.
41. Kluft C: Fibrinolysis risk markers for cardiovascular disease. Gynecol Endocrinol 7(suppl):45-53, 1993.
42. Brussaard HE, Gevers Leuven JA, Kluft C, Krans HMJ: Oestrogen replacement improves insulin response, lipoproteins and fibrinolysis in women with NIDDM [Abstract]. Diabetologia 38(suppl 1)A25, 1995.
43. Jaap AJ, Shore AC, Tooke JE: Diminished endothelium-dependent microvascular vasodilation in subjects with impaired glucose tolerance. Diabetic Med 11(suppl 2):522, 1994.